WELCOME TO KTNBIO

Published: 28 Jan 2025

Applications Are Open.  Apply Today.

Do you think your venture can bring affordable, high-quality health products and services closer to where patients are? You might belong in our next cohort. Learn more about our application process and selection criteria or click the button below to start your application now.

Investing in Innovation (i3) is a pan-African commercialization support program that aims to help scale fifteen (15) African healthtech startups who are working to advance healthcare access and delivery in Africa.

Sponsored by the Gates Foundation, MSD, Cencora, Chemonics, Endless Foundation, HELP Logistics, and Sanofi, i3 provides startups with up to $225K in risk-tolerant funding and connects them to leading healthcare organizations (donors, industry, global health institutions and governments) to scale their impact and produce measurable advances in access.

Investing in Innovation Health-Tech Startup

Benefits of Investing in Innovation Health-Tech Startup

• Access to Markets: i3 connects healthtech start-ups with large healthcare organizations including governments, donors, and global health institutions to drive adoption of start-ups’ offerings and scale.
• Risk-Tolerant Finance: i3 provides grant funding of $50K for early-stage innovators and up to $225K for growth-stage innovators, to overcome barriers to partnerships with large healthcare organizations e.g. WHO pre-qualification and regulatory compliance.
• Partnership Readiness Support: i3 provides a roadmap to help innovators meet the requirements for partnering with major healthcare organizations.
• Bespoke Deal Facilitation: i3 helps innovators refine their strategic positioning and increase the likelihood of successful partnerships and deals with large healthcare organizations.

CHECK OUT : Requirements for Immigrant and Nonimmigrant Visas

• Communications and Advocacy: i3 provides highly professionalized communications and advocacy, to amplify the work of African healthtech innovators in the global health landscape. Additionally, i3 works towards resolving key ecosystem barriers that impact healthtech innovation in Africa.

Requirements for Investing in Innovation Health-Tech Startup

i3’s current work seeks to catalyze the development of early- and growth-stage ventures building data-driven access to healthcare.

We seek to focus our impact on innovations that stand to benefit Africa, therefore we target program participants whose companies are owned, led or operated by African citizens and produce products for African customers.

Below is an overview of the starting criteria. Please refer to our detailed outline for full information on this cohort.

• African ownership and focus: Companies must be focused on serving African markets. We preference African-led and African-owned businesses.
• Tech-enabled and data-driven: Innovators must leverage technology and data to improve healthcare delivery or product distribution.
• Growth stage: Companies with demonstrated traction and scaling potential.
•  

Application Deadline

February 28, 2025

How to Apply

Interested and qualified? Go to Investing in Innovation on vc4a.com to apply